Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06701461 · ClinicalTrials.gov registry record · NA
Measurement of Osteoarthritic Patient Pain Through Electrodermal Activity Signals
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT06701461 is a NA study that has not yet begun recruiting, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 15 participants.
The verdict
NCT06701461, a NA study, has not yet begun recruiting, sponsored by Dartmouth-Hitchcock Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This pilot study aims to investigate the viability of using a smartwatch-based electrodermal activity (EDA) sensor to capture enough EDA signal to quantitatively assess pain in osteoarthritis subjects and test the feasibility of its methods and procedures for later use in subsequent larger-scale studies.
Interventions
- DEVICE Electrodermal Activity signal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2026-08 |
| Est. Completion | 2026-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06701461
The ClinicalTrials.gov registry entry for NCT06701461 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Electrodermal Activity signal is the first listed.
NCT06701461 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06701461 about?
NCT06701461 is a clinical study titled "Measurement of Osteoarthritic Patient Pain Through Electrodermal Activity Signals". This pilot study aims to investigate the viability of using a smartwatch-based electrodermal activity (EDA) sensor to capture enough EDA signal to quantitatively assess pain in osteoarthritis subjects and test the feasibility of its methods and procedures for later use in subsequent larger-scale stu...
What is the current status of trial NCT06701461?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2026-08. Estimated completion is 2026-10.
What interventions are being tested in trial NCT06701461?
The interventions under investigation include: Electrodermal Activity signal (DEVICE).
Who is sponsoring clinical trial NCT06701461?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.